ReviewZeitschrift fur Rheumatologie2026
[Chronic nonbacterial osteomyelitis/osteitis of childhood and adolescence].
Review in Zeitschrift fur Rheumatologie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Clinical spectrum of pediatric patients carrying heterozygous MEFV gene variants.European journal of pediatrics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Over the last 40 years, the clinical picture of chronic osteomyelitis without a microbiological cause has increasingly been described as chronic nonbacterial osteomyelitis/osteitis (CNO) in the sense of an entity. With the sharpening of the clinical picture, the disease designations became increasingly homogeneous. Consequently, an internationally agreed classification of CNO for childhood has recently been published, which is based on two studies on clinical diagnostic criteria. With regard to pathophysiology, findings have also shown that CNO can be categorised as an auto-inflammatory disease. However, it remains a diagnosis of exclusion. Quite a few differential diagnostic entities must be considered, which are almost indistinguishable from genuine CNO both clinically and morphologically. For the latter, a genetic or metabolic cause is still largely unknown, although various activations of inflammatory pathways have been described. In the meantime, the basis has been laid for conducting controlled studies in which, in addition to the classification, parameters for disease activity and suggestions for inactive disease and remission have been published.This review describes the historical development towards a now more clearly defined disease. It discusses diagnostic and therapeutic algorithms using the example of an adolescent patient with spinal and extremity manifestations.
Indexed as
Identifiers
41125838What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.